142 related articles for article (PubMed ID: 34324244)
1. Immunogenicity of varicella zoster vaccine in pediatric liver transplantation.
Atjayutpokin T; Treepongkaruna S; Apiwattanakul N; Techasaensiri C; Lertudomphonwanit C; Getsuwan S; Boonsathorn S
Pediatr Int; 2022 Jan; 64(1):e14934. PubMed ID: 34324244
[TBL] [Abstract][Full Text] [Related]
2. Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic.
Posfay-Barbe KM; Pittet LF; Sottas C; Grillet S; Wildhaber BE; Rodriguez M; Kaiser L; Belli DC; McLin VA; Siegrist CA
Am J Transplant; 2012 Nov; 12(11):2974-85. PubMed ID: 22994936
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of varicella-zoster virus vaccine by different routes of administration: Comparable vaccination efficacy of one-fifth dose intradermal vaccination to conventional subcutaneous vaccination.
Nakamura-Nishimura Y; Shinkuma S; Miyagawa F; Haredy A; Gomi Y; Yamanishi K; Asada H
J Dermatol Sci; 2022 May; 106(2):86-92. PubMed ID: 35437206
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant Recipients.
L'Huillier AG; Hirzel C; Ferreira VH; Ierullo M; Ku T; Selzner N; Schiff J; Juvet S; Miao C; Schmid DS; Humar A; Kumar D
Transplantation; 2021 Oct; 105(10):2316-2323. PubMed ID: 33528118
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.
Sasadeusz J; Prince HM; Schwarer A; Szer J; Stork A; Bock HL; Povey M; Nicholson O; Innis BL
Transpl Infect Dis; 2014 Dec; 16(6):1024-31. PubMed ID: 25272081
[TBL] [Abstract][Full Text] [Related]
7. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults.
Macaladad N; Marcano T; Guzman M; Moya J; Jurado F; Thompson M; Meechan C; Li D; Schlienger K; Chan I; Sadoff J; Schödel F; Silber JL
Vaccine; 2007 Mar; 25(11):2139-44. PubMed ID: 17250932
[TBL] [Abstract][Full Text] [Related]
9. Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.
Wittek AE; Arvin AM; Koropchak CM
J Clin Microbiol; 1983 Nov; 18(5):1146-9. PubMed ID: 6315766
[TBL] [Abstract][Full Text] [Related]
10. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
[TBL] [Abstract][Full Text] [Related]
13. Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine.
Perciani CT; Jaoko W; Walmsley S; Farah B; Mahmud SM; Ostrowski M; Anzala O; Team KI; MacDonald KS
BMJ Open; 2017 Sep; 7(9):e017391. PubMed ID: 28939581
[TBL] [Abstract][Full Text] [Related]
14. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents.
Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Wittke F; Jotterand V
Hum Vaccin Immunother; 2021 Nov; 17(11):4183-4189. PubMed ID: 34702124
[TBL] [Abstract][Full Text] [Related]
15. Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
Speth F; Hinze CH; Andel S; Mertens T; Haas JP
Pediatr Rheumatol Online J; 2018 Mar; 16(1):15. PubMed ID: 29499726
[TBL] [Abstract][Full Text] [Related]
16. Long-term Seroprotection of Varicella-zoster Immunization in Pediatric Liver Transplant Recipients.
Verolet CM; Pittet LF; Wildhaber BE; McLin VA; Rodriguez M; Grillet S; Siegrist CA; Posfay-Barbe KM
Transplantation; 2019 Nov; 103(11):e355-e364. PubMed ID: 31335765
[TBL] [Abstract][Full Text] [Related]
17. Varicella vaccination in pediatric oncology patients without interruption of chemotherapy.
van de Wetering MD; Vossen MT; Jansen MH; Caron HN; Kuijpers TW
J Clin Virol; 2016 Feb; 75():47-52. PubMed ID: 26780112
[TBL] [Abstract][Full Text] [Related]
18. Serological and T Cell Responses After Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis.
Righi E; Carnelutti A; La Rosa A; Sartor A; Tulissi P; Gallo T; Ivaldi F; Bassetti M
Viral Immunol; 2019 Apr; 32(3):151-157. PubMed ID: 30694731
[TBL] [Abstract][Full Text] [Related]
19. Pediatric vaccine-strain herpes zoster: a case series.
Dreyer S; Hemarajata P; Hogeling M; Henderson GP
Pediatr Dermatol; 2017 Nov; 34(6):665-667. PubMed ID: 28944968
[TBL] [Abstract][Full Text] [Related]
20. Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
Levin MJ; Schmader KE; Pang L; Williams-Diaz A; Zerbe G; Canniff J; Johnson MJ; Caldas Y; Cho A; Lang N; Su SC; Parrino J; Popmihajlov Z; Weinberg A
J Infect Dis; 2016 Jan; 213(1):14-22. PubMed ID: 26452397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
